CEO Patrik Byhmer visited Biostock Studio and comments on Q1 2020 report in interview.
“Redsense Medical has developed an alarm system that detects and warns of life-threatening blood leakage in connection with dialysis treatment. This is after a sales increase of 154 percent and the company’s first listed net profit as CEO Patrik Byhmer visits BioStock Studio to talk about the first quarter of 2020. In the interview we hear about the challenges with logistics in corona times and how the company solved this, as well as how to has worked to increase production capacity to meet rising demand.”
The interview was held in Swedish.